{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:16:57Z","timestamp":1784157417835,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.intimp.2016.01.010","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T20:03:45Z","timestamp":1453406625000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["TLR4 signaling mediates AP-1 activation in an MPTP-induced mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Xu-Dong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Fu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.01.010_bb0005","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0193-953X(05)70344-0","article-title":"Parkinson's disease","volume":"20","author":"Barbosa","year":"1997","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.intimp.2016.01.010_bb0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1742-2094-11-86","article-title":"Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease","volume":"11","author":"Noelker","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2016.01.010_bb0015","first-page":"487450","article-title":"The endotoxin-induced neuroinflammation model of Parkinson's disease","volume":"2011","author":"Tufekci","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.intimp.2016.01.010_bb0020","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/srep01393","article-title":"Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease","volume":"3","author":"Noelker","year":"2013","journal-title":"Sci. Report."},{"key":"10.1016\/j.intimp.2016.01.010_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.01.014","article-title":"Biological role of Toll-like receptor-4 in the brain","volume":"268","author":"Trotta","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2016.01.010_bb0030","first-page":"90","article-title":"Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients","volume":"2","author":"Doorn","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.intimp.2016.01.010_bb0035","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2016.01.010_bb0040","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/srep01393","article-title":"Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease","author":"Noelker","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2016.01.010_bb0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.expneurol.2012.06.025","article-title":"Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein","volume":"237","author":"Watson","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2016.01.010_bb0050","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1432-1033.1994.tb18776.x","article-title":"Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1","volume":"221","author":"Galter","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.intimp.2016.01.010_bb0055","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1096\/fj.03-1075fje","article-title":"Estrogen and neuroprotection: higher constitutive expression of glutaredoxin in female mice offers protection against MPTP-mediated neurodegeneration","volume":"18","author":"Kenchappa","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2016.01.010_bb0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1290\/0512083.1","article-title":"Activation of activator protein-1 in mouse brain regions exposed to simulated microgravity","volume":"42","author":"Sarkar","year":"2006","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.intimp.2016.01.010_bb0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0955-0674(97)80068-3","article-title":"AP-1 function and regulation","volume":"9","author":"Karin","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.intimp.2016.01.010_bb0070","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1242\/jcs.01589","article-title":"AP-1 subunits: quarrel and harmony among siblings","volume":"117","author":"Hess","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.intimp.2016.01.010_bb0075","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.freeradbiomed.2005.08.006","article-title":"Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes","volume":"39","author":"Wu","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2016.01.010_bb0080","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.intimp.2016.01.010_bb0085","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"K.B.J.","year":"2001"},{"key":"10.1016\/j.intimp.2016.01.010_bb0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00011-015-0828-7","article-title":"TLR1 expression in mouse brain was increased in a KA-induced seizure model","volume":"64","author":"Wang","year":"2015","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2016.01.010_bb0095","first-page":"435","article-title":"A simple quantitative bradykinesia test in MPTP-treated mice","volume":"50","author":"Ogawa","year":"1985","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.intimp.2016.01.010_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.intimp.2016.01.010_bb0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2174\/187152712800792901","article-title":"Overview of tyrosine hydroxylase in Parkinson's disease","volume":"11","author":"Zhu","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets."},{"key":"10.1016\/j.intimp.2016.01.010_bb0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.410360213","article-title":"Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy","volume":"36","author":"Kastner","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2016.01.010_bb0115","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1038\/sj.onc.1204389","article-title":"AP-1 in mouse development and tumorigenesis","volume":"20","author":"Jochum","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2016.01.010_bb0120","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1038\/sj.onc.1204381","article-title":"The mammalian Jun proteins: redundancy and specificity","volume":"20","author":"Mechta-Grigoriou","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2016.01.010_bb0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pneurobio.2006.03.006","article-title":"Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain","volume":"78","author":"Raivich G1 BA","year":"2006","journal-title":"Prog Neurobiol."},{"key":"10.1016\/j.intimp.2016.01.010_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(01)00551-0","article-title":"The molecular biology and nomenclature of the activating transcription factor\/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis","volume":"273","author":"Hai","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.intimp.2016.01.010_bb0135","first-page":"1103","article-title":"Study of the changing levels of AP-1 in hippocampus of epileptic mouse","volume":"28","author":"ZX","year":"2012","journal-title":"J. Immunicity."},{"key":"10.1016\/j.intimp.2016.01.010_bb0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0306-4522(02)00064-7","article-title":"Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy","volume":"112","author":"Riban","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2016.01.010_bb0145","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00702-013-1149-z","article-title":"A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease","volume":"121","author":"Ambrosi","year":"2014","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.intimp.2016.01.010_bb0150","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1471-4159.2009.06459.x","article-title":"AP-1 inhibitory peptides are neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures","volume":"112","author":"Meade","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2016.01.010_bb0155","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2016.01.010_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00207450108986528","article-title":"Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine","volume":"109","author":"Rodrigues","year":"2001","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.intimp.2016.01.010_bb0165","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1471-4159.2002.00990.x","article-title":"Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease","volume":"82","author":"Breidert","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2016.01.010_bb0170","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916300108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916300108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T22:16:39Z","timestamp":1567548999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916300108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":34,"alternative-id":["S1567576916300108"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.01.010","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR4 signaling mediates AP-1 activation in an MPTP-induced mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}